Catalyst Wire Dossier Catalyst Wire Dossier

rhDNase eye drops

recombinant human DNase I
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for rhDNase eye drops, covering 2021-08-10 to 2021-08-10. Get the full timeline:

Most recent: Clinical Trial Update: rhDNase Eye Drops in Patients With Ocular Graft-Vs.-Host Disease [Phase 1, Phase 2]

See pricing